The Nucleolus Gets the Silent Treatment  by Feinberg, Andrew P.
Cell Stem Cell
PreviewsHerbert, B.S., Gellert, G.C., Hochreiter, A.,
Pongracz, K., Wright, W.E., Zielinska, D., Chin,
A.C., Harley, C.B., Shay, J.W., and Gryaznov,
S.M. (2005). Oncogene 24, 5262–5268.
Pucci, F., Gardano, L., and Harrington, L. (2013).
Cell Stem Cell 12, 479–486.Townsley, D.M., Dumitriu, B., and Young, N.S.
(2014). Blood 124, 2775–2783.Vicente-Duen˜as, C., Barajas-Diego, M., Romero-
Camarero, I., Gonza´lez-Herrero, I., Flores, T., and
Sa´nchez-Garcı´a, I. (2012). Oncotarget 3, 261–266.Cell Stem Cell 15,Wang, J., Lu, X., Klein, C.A., and Rudolph, K.L.
(2014). Blood, in press. Published online
September 16, 2014. http://dx.doi.org/10.1182/
blood-2014-04-568055.
Ye, J., Renault, V.M., Jamet, K., and Gilson, E.
(2014). Nat. Rev. Genet. 15, 491–503.The Nucleolus Gets the Silent TreatmentAndrew P. Feinberg1,*
1Center for Epigenetics and Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
*Correspondence: afeinberg@jhu.edu
http://dx.doi.org/10.1016/j.stem.2014.11.017
In this issue of Cell Stem Cell, Savic et al. (2014) and Kim et al. (2014) provide insight into how global hetero-
chromatin condensation and LIN28 sequestration in embryonic stem cells are independent mechanisms
regulating pluripotency in the oft-overlooked nucleolus.Even though we have been aware of the
nucleolus for 180 years, and it is the
largest structure in the nucleus, it gets
little attention compared to the nucleus
(15,000 versus 374,000 cites). And much
less attention is paid to its role in epige-
netics (25 Pubmed citations) or hetero-
chromatin (800 citations) compared to its
role in ribosomal gene transcription.
That’s actually a bit strange for both his-
torical and biological reasons. Historical-
ly, because in the 1930s, Emil Heitz
described heterochromatic satellite re-
gions near the nucleolus, and Barbara
McClintock described the nucleolar-orga-
nizing region’s association with hetero-
chromatin. And biologically, because
most ribosomal genes are actually not
expressed in normal cells, and their
silencing by heterochromatin is necessary
to prevent chromosomal rearrangements
and excessive growth.
In this issue of Cell Stem Cell, two
papers now provide insight into indepen-
dent nucleolar mechanisms regulating
pluripotency in embryonic stem cells
(ESCs). Much as people now widely
accept the importance of the nuclear
membrane in organizing heterochromatin
structure, and emerging work connects
3D genome organization with regulation
of ESC fate (reviewed in Gorkin et al.,
2014), the nucleolus has so far gotten
the silent treatment in this area. The
work by Savic et al. addresses one mech-anism for heterochromatin formation dur-
ing lineage commitment as mouse ESCs
(mESCs) differentiate (Savic et al., 2014).
They specifically addressed the role of
the long noncoding RNA pRNA, which
is the mature form of the processed
2 kb long intergenic spacer (IGS)-rRNA,
already known to interact with nucleolar
repressor factor TIP5 in generating rDNA
heterochromatin. They first showed that
ribosomal DNA methylation is decreased
in induced pluripotent stem cells and het-
erochromatin marks H3K9me2/3 and
H3K27me3 increase during differentia-
tion; and the changes in both directions
are associated with expected increases
and decreases in transcription, respec-
tively. They then transfected mESCs with
pRNA, which led to TIP5 accumulation in
nucleoli and induced heterochromatic
rDNAwith an increase in CpGmethylation
and H3K9me2 at the rDNA promoter—
and mutagenesis experiments showed
that this was dependent on an intact
30-pRNA stem-loop structure, but not
the pRNA-TIP5 association itself. Thus
pRNA guides TIP5 to rDNA through its
hairpin structure and establishes ribo-
somal gene heterochromatin. Moreover
pRNA expression and TIP5 accumulation
led to a dramatic general increase in
condensed perinucleolar heterochromat-
in, as well as total levels of H3K9me2 in
the nucleus, an indicator of large-scale
heterochromatin formation.Another paper in this same issue, by
Kim et al., identifies a nucleolar targeting
mechanism by which a histone methyl-
transferase—normally these are involved
in the epigenetic machinery—affects plu-
ripotency in human ESCs (Kim et al.,
2014). The study addresses the mecha-
nism by which the key pluripotency
factor LIN28 represses processing of
let-7 miRNA (from the pri-let-7 to the
pre-let-7) to maintain self-renewal. In
the nucleus, LIN28 processing is less
well understood than in the cytoplasm,
which involves recruitment of TUT4/7
to induce oligo-uridylation of pre-let-7,
which appears to both prevent its Dicer-
induced processing into mature let-7
and render it susceptible to digestion by
the Dis3L2 exonuclease (reviewed in
Shyh-Chang and Daley, 2013). The au-
thors were pursuing a relatively recent
thread of studies on the nature and effect
of methylation of core pluripotency
factors. Specifically they investigated
the effect of SET7/9 monomethylase on
LIN28A, but not the paralogous LIN28B,
and identified the methylated residue
as lysine 135. Remarkably, the K135
methylation leads to nucleolar localiza-
tion of LIN28A and sequestration,
preventing LIN28A processing indepen-
dently of TUTase. Interestingly, the
K135 site of LIN28A is homologous to
the nucleolar localizing signal region of
LIN28B, which was already known toDecember 4, 2014 ª2014 Elsevier Inc. 675
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Previewshave a role in the nucleolus (Piskounova
et al., 2011).
Savic et al. dance with a bee in my
own bonnet when they consider that the
progressive condensation of euchromatin
into heterochromatin in nuclear structures
reduces epigenetic and thus gene
expression plasticity during differentiation
and this processmight bemodulated dur-
ing important processes such as the
epithelial-mesenchymal transition (EMT)
and cancer. The mechanism we have
studied is the role of Large Organized
Chromatin lysine (K)-modifications
(LOCKs), typically H3K9me2/3 in regu-
lating phenotypic plasticity (Wen et al.,
2009). These largely overlap structurally
defined lamin-associated domains
(LADs). LOCKs support formation of orga-
nized chromatin structures, or
‘‘speckles,’’ in the nucleus during he-
matopoietic lineage commitment (Chen
et al., 2012). EMT induced by TGF-b
causes reversible loss of LOCKs and
LADs, and inhibition of this chromatin de-
condensation by lysine-specific demethy-
lase inhibitors abrogates downstream
phenotypes of EMT such as chemoresist-
ance and cellular migration. Interestingly,
the mechanism described by Savic et al.
also appears to induce LOCKs on a
genome scale. We are only beginning to
understand the key role of nuclear struc-
tures in organizing heterochromatin do-
mains in the nucleus. Intriguingly, though,
heterochromatin domains can shuffle
between their nuclear (LAD/LOCK) and676 Cell Stem Cell 15, December 4, 2014 ª2nucleolar homes. One should also recall
that the first nuclear mapping of CTCF, a
key organizer of chromosome territories
and a regulator of genomic imprinting,
was to the nucleolus (Yusufzai et al.,
2004).
Finally, both of the current papers
emphasize the importance of noncoding
RNAs in the nucleolus’s role in regulating
pluripotency and differentiation. This is in
keeping with the observations that the
X-inactivation RNA XIST is localized to
the nucleolar periphery. The long anti-
sense RNA LIT1, which regulates one
of the imprinted Beckwith-Wiedemann
syndrome domains involved in Wilms
and other tumors, is also localized to
the nucleolus, which appears to partici-
pate in the orchestration of large-scale
H3K9 and H3K27 methylation and gene
silencing (Pandey et al., 2008).
Given that the nucleolus acts in such
important structural ways without an
actual membrane, it is fascinating that its
formation requires only the Pol I machin-
ery and the factors UBF and SL-1 in
concert with active genomic nucleolar
organizing regions (NORs) (reviewed in
Diesch et al., 2014). The current reports
support the idea that these processes
and their developmental control require
the presence of noncoding RNAs that
likely facilitate the organization of
‘‘anatomical’’ domains beyond the forma-
tion of the nucleolus. The last day of this
month marks the 500th birthday of the
Belgian anatomist Andries van Wesel014 Elsevier Inc.(often Latinized to Vesalius), who defined
human anatomy and argued that function
follows form. He would be thrilled to learn
that we are finally dissecting the nucleus
into its components and learning the
same lesson.
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